Your browser doesn't support javascript.
loading
The Glycosylated N-Terminal Domain of MUC1 Is Involved in Chemoresistance by Modulating Drug Permeation Across the Plasma Membrane.
Miyazaki, Kaori; Kishimoto, Hisanao; Kobayashi, Hanai; Suzuki, Ayaka; Higuchi, Kei; Shirasaka, Yoshiyuki; Inoue, Katsuhisa.
Afiliação
  • Miyazaki K; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Kishimoto H; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Kobayashi H; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Suzuki A; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Higuchi K; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Shirasaka Y; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.).
  • Inoue K; Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences (K.M., H.Ki, H.Ko, A.S., K.H., and K.I.) and Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University (Y.S.) kinoue@toyaku.ac.jp.
Mol Pharmacol ; 103(3): 166-175, 2023 03.
Article em En | MEDLINE | ID: mdl-36804202
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Mol Pharmacol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Mol Pharmacol Ano de publicação: 2023 Tipo de documento: Article